Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tina, Ding"'
Autor:
Andrew B. Wong, Minliang Lai, Anthony Fu, Tina Ding, Lin-Wang Wang, Letian Dou, Peidong Yang, Connor G. Bischak, Naomi S. Ginsberg, Jie Ma, Yi Yu, Nikolay Kornienko, Samuel W. Eaton, A. Paul Alivisatos
Publikováno v:
Science. 349:1518-1521
Flat perovskite crystals Bulk crystals and thick films of inorganic-organic perovskite materials such as CH 3 NH 3 PbI 3 have shown promise as active material for solar cells. Dou et al. show that thin films—a single unit cell or a few unit cells t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59f166ea172dbc0e753992f58582f4e0
https://doi.org/10.1126/science.aac7660
https://doi.org/10.1126/science.aac7660
Publikováno v:
Medicine. 42:237-242
The management of rheumatoid arthritis (RA) has changed substantially over recent years. The emphases are now on early recognition of persistent synovitis in primary care, rapid referral to specialist services and prompt use of disease-modifying anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff1193ad517551c759ee7d65f55ebe5f
https://doi.org/10.1016/j.mpmed.2014.02.004
https://doi.org/10.1016/j.mpmed.2014.02.004
Publikováno v:
Prescriber. 21:48-52
With increasingly complex drug combinations and new biological drugs being used, there is a need for good communication between primary and secondary care for optimal RA management. This article addresses the issues that may arise in the shared manag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8b220d42f72859b5a09f7391e7aeefc
https://doi.org/10.1002/psb.627
https://doi.org/10.1002/psb.627
Autor:
Tina Ding, Chris Deighton
Publikováno v:
Medicine. 38:172-176
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a64b64a0553e3f9bb4e3981955c7f54c
https://doi.org/10.1016/j.mpmed.2009.12.003
https://doi.org/10.1016/j.mpmed.2009.12.003
Publikováno v:
Health Affairs. 28:w595-w606
Based on simulated bill paying, this paper examines trends in comprehensiveness of coverage, out-of-pocket spending for medical services, underinsurance, and the affordability of employer-based insurance from 2004 to 2007. Data are from MarketScan me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32b474629e08678a91da002d071bb997
https://doi.org/10.1377/hlthaff.28.4.w595
https://doi.org/10.1377/hlthaff.28.4.w595
Autor:
Chris Deighton, Tina Ding
Publikováno v:
Future Rheumatology. 2:587-597
Anti-TNF drugs have revolutionized the treatment of rheumatoid arthritis (RA). Concerns about risks of infection and malignancy with these agents have led to scrutiny of available data. Patients with severe, active RA are more prone to infection and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f163df985b2bbdc164af7ed62c30d08
https://doi.org/10.2217/17460816.2.6.587
https://doi.org/10.2217/17460816.2.6.587
Autor:
Tina Ding, Chunliu Zhan, Irma E. Arispe, Catharine W. Burt, Judith Shinogle, Daniel Stryer, Edward Kelley
Publikováno v:
The Joint Commission Journal on Quality and Patient Safety. 31:372-378
Adverse d[rug events (ADEs) are a well-recognized patient safety 4concern, but their magnitude is unknown. Ambulatory viisits for treating adverse drug effects (VADEs) as recordeed in national surveys offer an alternative way to estimatte the nationa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97beb0de264a30364af7fbf8d000380f
https://doi.org/10.1016/s1553-7250(05)31050-6
https://doi.org/10.1016/s1553-7250(05)31050-6
Autor:
Tina Ding, Chris Deighton
Publikováno v:
Future Prescriber. 10:6-8
Anti-TNF drugs are a major treatment advance in the management of inflammatory disorders such as rheumatoid arthritis, and are typically considered following unsuccessful treatment with conventional disease-modifying antirheumatic drugs (DMARDs). Drs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ef4c3f7c0d2388f288da3fe7db4df67
https://doi.org/10.1002/fps.55
https://doi.org/10.1002/fps.55
Autor:
Jo Ledingham, Ailsa Bosworth, Mark Lunt, Raashid Luqmani, Chris Deighton, Patrick Kiely, Josh Dixey, Marwan Bukhari, Kate Gadsby, Rikki Abernethy, Andrew Ostor, Kimme L. Hyrich, Diana Finney, Tina Ding, Frank McKenna
Publikováno v:
Rheumatology (Oxford, England). 50(12)
The Standards, Audit and Guidelines Working Group (SAGWG) of the British Society for Rheumatology (BSR) have recently updated the guidelines on eligibility for anti-TNF drugs in RA [1] and have updated the anti-TNF safety and efficacy guidelines [2]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4b5f6a614fa0cf5516d0a8d893814d5
https://pubmed.ncbi.nlm.nih.gov/21546350
https://pubmed.ncbi.nlm.nih.gov/21546350
Autor:
Diana Finney, Rikki Abernethy, Tina Ding, Frank McKenna, Raashid Luqmani, Sarah Westlake, Kimme L. Hyrich, Ailsa Bosworth, Marwan Bukhari, Andrew Ostor, Mark Lunt, Chris Deighton, Patrick Kiely, Kate Gadsby, Jo Ledingham, Josh Dixey
Publikováno v:
Rheumatology (Oxford, England). 49(11)
Inhibitors of TNF-a represent important treatment advances for a number of inflammatory conditions, including RA. TNF-a inhibitors offer a targeted strategy that contrasts with the non-specific immunosuppressive agents traditionally used to treat mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3f48c667dd10f68d62b3b2964790c89
https://pubmed.ncbi.nlm.nih.gov/20837498
https://pubmed.ncbi.nlm.nih.gov/20837498